Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC January 12, 20240CommentsEN NL Read More
Jaarverslag 2023 (officiële ESEF-versie) December 30, 20230CommentsJaarverslag 2023 (officiële ESEF-versie)Read More
Annual report 2023 (official ESEF version) December 30, 20230CommentsAnnual report 2023 (official ESEF version)Read More
Oxurion Avoids Bankruptcy, Announces Board and Management Changes and Enters into Binding Letter of Intent with its Main Creditor Atlas December 28, 20230CommentsEN NL Read More
Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC December 1, 20230CommentsEN NL Read More
Oxurion Discloses Topline Data from KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema November 20, 20230CommentsEN NL Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas November 19, 20230CommentsEN NL Read More
Oxurion Receives EUR 1.0 Million under Amended Atlas Funding Program Total of EUR 3.5 Million in Unconditional Funding Allowing Company to Reach Topline Data from KALAHARI Trial This Year November 16, 20230CommentsEN Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas November 16, 20230CommentsEN NL Read More
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC November 15, 20230CommentsEN NL Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas November 6, 20230CommentsEN NL Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas November 3, 20230CommentsEN NL Read More
Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC October 30, 20230CommentsEN NL Read More
Oxurion Receives EUR 1.5 Million under Amended Atlas Funding Program; Total of EUR 3.5 Million in Unconditional Funding Allowing Company to Achieve Topline Data from KALAHARI Trial October 25, 20230CommentsEN Read More
Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC October 20, 20230CommentsEN NL Read More
